Physician profile
Jon D Simmons
NPI 1376715755
$3,114.96
in general payments reported to CMS, 2019-2025
30 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $307 · 2021: $821 · 2022: $127 · 2023: $419 · 2024: $469 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $390.77 | 2019-2024 | Ovitex 2s |
| Depuy Synthes Sales INC. | $348.55 | 2019-2022 | |
| Bsn Medical INC | $310.04 | 2023-2025 | |
| Smith+Nephew, INC. | $197.91 | 2020-2024 | Versajet, Collagenase Santyl, Oasis |
| Baxter Healthcare | $184.36 | 2019-2025 | Recothrom, Tisseel |
| Kerecis Limited | $168.53 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Urgo Medical North America, LLC | $164.50 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Polynovo North America LLC | $162.71 | 2023-2025 | Novosorb Btm |
| Kls-Martin L.P. | $155.87 | 2019-2021 | |
| Integra Lifesciences Corporation | $136.27 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $134.73 | 2021 | |
| Allergan, INC. | $125.00 | 2019 | |
| Merck Sharp & Dohme LLC | $120.76 | 2019-2025 | Zerbaxa, Dificid |
| Zimmer Biomet Holdings, INC. | $95.34 | 2019-2025 | Ribfix Blu Advantage |
| Abbvie INC. | $76.07 | 2023 | Vraylar |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polarityte, INC. | $60.83 | 2019 | |
| Intuitive Surgical, INC. | $47.32 | 2024 | |
| Teleflex LLC | $28.90 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $23.56 | 2019 | |
| Arbor Pharmaceuticals, INC. | $20.11 | 2019 | |
| Mallinckrodt Hospital Products INC. | $19.48 | 2022 | |
| Z-Medica, LLC | $18.21 | 2019 | |
| Ethicon US, LLC | $18.20 | 2019 | |
| Acera Surgical, INC. | $18.10 | 2019 | |
| Csl Behring | $17.89 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.92 | 2021 | |
| Astellas Pharma US INC | $15.26 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $14.65 | 2024 | |
| Acell, INC. | $13.11 | 2019 | |
| Portola Pharmaceuticals, LLC | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.